Indexé dans
- Ouvrir la porte J
- Genamics JournalSeek
- Clés académiques
- JournalTOCs
- Infrastructure nationale des connaissances en Chine (CNKI)
- Répertoire des périodiques d'Ulrich
- RechercheRef
- Université Hamdard
- EBSCO AZ
- Répertoire d'indexation des résumés pour les revues
- OCLC - WorldCat
- Publions
- Fondation genevoise pour la formation et la recherche médicales
- Pub européen
- Google Scholar
Liens utiles
Partager cette page
Dépliant de journal
Revues en libre accès
- Agriculture et aquaculture
- Alimentation et nutrition
- Biochimie
- Bioinformatique et biologie des systèmes
- Business & Management
- Chimie
- Génétique et biologie moléculaire
- Immunologie & Microbiologie
- Ingénierie
- La science des matériaux
- Neurosciences & Psychologie
- Science générale
- Sciences cliniques
- Sciences environnementales
- Sciences médicales
- Sciences pharmaceutiques
- Sciences vétérinaires
- Soins infirmiers et soins de santé
Abstrait
Intensified Therapy Followed by Autologous Stem-Cell Transplantation (ASCT) versus Conventional Therapy as First-Line Treatment of Follicular Lymphoma
Lida Wang, Liping Liu, Huanwen Ma and Zhixin Sheng
To define the treatment effect of intensified therapy followed by autologous stem-cell transplantation (ASCT) compared with conventional therapy as first-line treatment of patients with follicular lymphoma (FL) in terms of overall survival (OS) and event-free survival (EFS). Medline, Embase, the Cochrane controlled trials register and the Science Citation Index were searched. Four trials were identified, covering a total of 941 subjects. The random- effects summary Hazard Ritio (HR) comparing the treatment effect on OS between intensified and conventional therapy was 0.95 [0.70, 1.30] (P=0.75), indicating that no additional survival benefit was derived from the intensified therapy followed by ASCT. A significant benefit of intensified therapy followed by ASCT as first-line treatment was detected in terms of EFS: the random-effects summary HR (intensified versus conventional therapy) was 0.59 [0.44, 0.79] (P<0.001). In conclusion, despite its superior EFS, intensified therapy followed by ASCT does not improve OS compared with conventional therapy.